BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1438368)

  • 1. Resolution of the subcellular site of very long-chain fatty acid beta-oxidation in human skin fibroblasts using a novel approach.
    Jakobs BS; Wanders RJ
    Prog Clin Biol Res; 1992; 375():231-8. PubMed ID: 1438368
    [No Abstract]   [Full Text] [Related]  

  • 2. A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir.
    Caspary F; Elliott G; Navé BT; Verzaal P; Rohrbach M; Das PK; Nagelkerken L; Nieland JD
    Br J Dermatol; 2005 Nov; 153(5):937-44. PubMed ID: 16225603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitors of beta-oxidation of fatty acids (review)].
    Kendysh IN
    Vopr Med Khim; 1984; 30(2):18-27. PubMed ID: 6377685
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the formation of lactate and pyruvate from glucose in cultured skin fibroblasts: implications for detection of respiratory chain defects.
    Wijburg FA; Feller N; Scholte HR; Przyrembel H; Wanders RJ
    Biochem Int; 1989 Sep; 19(3):563-70. PubMed ID: 2554914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
    Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
    Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between gluconeogenesis and fatty acid oxidation in isolated sheep hepatocytes.
    Chow JC; Jesse BW
    J Dairy Sci; 1992 Aug; 75(8):2142-8. PubMed ID: 1401366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menadione partially restores NADH-oxidation and ATP-synthesis in complex I deficient fibroblasts.
    Wijburg FA; Feller N; de Groot CJ; Wanders RJ
    Biochem Int; 1990 Oct; 22(2):303-9. PubMed ID: 2128595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid-induced effect on glucagon secretion is mediated via fatty acid oxidation.
    Hong J; Jeppesen PB; Nordentoft I; Hermansen K
    Diabetes Metab Res Rev; 2007 Mar; 23(3):202-10. PubMed ID: 16802400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced induction of carbohydrate utilization by inhibition of fatty acid oxidation in myocytes from diabetic animals.
    Abdel-aleem S; Sharwi S; Badr M; Sayed-Ahmed M; Anstadt MP; Lowe JE
    Horm Metab Res; 1995 Feb; 27(2):104-6. PubMed ID: 7759056
    [No Abstract]   [Full Text] [Related]  

  • 10. Respiratory chain defects in the mitochondria of cultured skin fibroblasts from three patients with lacticacidemia.
    Robinson BH; Ward J; Goodyer P; Baudet A
    J Clin Invest; 1986 May; 77(5):1422-7. PubMed ID: 3009544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
    J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid oxidation intermediates and the effect of fasting on oxidation in red and white skeletal muscle.
    Carroll JE; Villadiego A; Morse DP
    Muscle Nerve; 1983 Jun; 6(5):367-73. PubMed ID: 6136912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices.
    Vickers AE; Bentley P; Fisher RL
    Toxicol In Vitro; 2006 Oct; 20(7):1173-82. PubMed ID: 16545538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
    Thupari JN; Pinn ML; Kuhajda FP
    Biochem Biophys Res Commun; 2001 Jul; 285(2):217-23. PubMed ID: 11444828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum factors that stimulate fatty acid oxidation: physiological specificity.
    Stanisz J; Wice BM; Kennell DE
    J Cell Physiol; 1986 Jan; 126(1):141-6. PubMed ID: 3944194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytanic acid alpha-oxidation in human cultured skin fibroblasts.
    Singh I; Lazo O; Kalipada P; Singh AK
    Biochim Biophys Acta; 1992 Dec; 1180(2):221-4. PubMed ID: 1463774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: structure-activity relationships.
    Tune BM; Hsu CY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):873-80. PubMed ID: 7932199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conclusive evidence that very-long-chain fatty acids are oxidized exclusively in peroxisomes in human skin fibroblasts.
    Jakobs BS; Wanders RJ
    Biochem Biophys Res Commun; 1991 Aug; 178(3):842-7. PubMed ID: 1872864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry.
    Law LK; Tang NL; Hui J; Ho CS; Ruiter J; Fok TF; Wanders RJ; Lam CW
    Clin Chim Acta; 2007 Jul; 382(1-2):25-30. PubMed ID: 17442290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid oxidation inhibition with PPARalpha activation (FOXIB/PPARalpha) for normalizing gene expression in heart failure?
    Rupp H; Rupp TP; Maisch B
    Cardiovasc Res; 2005 Jun; 66(3):423-6. PubMed ID: 15914105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.